CAS: 38202-27-6; Ethyl N-(Mesitylsulfonyl)Oxyacetimidate

上下游产品

CAS号773-64-8 2,4,6-三甲基苯磺酰氯 | CAS号10576-12-2 乙酰羟肟酸乙酯 | CAS号1667-04-5 2,4,6-三甲基氯苯 | CAS号36016-40-7 2-[(氨基氧基)磺酰]-1,... | CAS号16182-15-3 2,4,6-三甲基苯磺酰肼

乙酰羟肟酸乙酯,2,4,6-三甲基氯苯置于三乙胺体系中,用 N,N-二甲基甲酰胺 作为反应溶剂,以92%的收率获得产物o-(2,4,6-三甲基苯磺酰基)乙酰羟肟酸乙酯
参考文献: Compounds For The Treatment Of Hepatitis C[fr] Composés Destinés Au Traitement De L'Hépatite C
标题: Compounds For The Treatment Of Hepatitis C[fr] Composés Destinés Au Traitement De L'Hépatite C

专利信息

专利号:US-2023219994-A1
优先权日:2019-08-14
标 题:Modified nucleoside and synthesis method therefor
发明人：CAI YUNSONG; LI HANGWEN; LIU LIANXIAO; LI NING
权利人:STEMIRNA THERAPEUTICS CO LTD
摘要:A modified cytidine compound, that is, an aminooxy group is modified at the 4-position of a cytidine pyrimidine ring to produce derivative cytidine and nucleic acid containing the derivative cytidine, such as RNA. The expression level of the nucleic acid containing the modified cytidine, in particular mRNA, in the body is significantly improved.